Oncology

ERC Consolidator Grant

European grants for research into stomach cancer and motor control

Neuroscientist Zhenyu Gao and molecular geneticist Miao-Ping Chien from Erasmus MC have been awarded Consolidator Grants from the European Research Council. They will use this 2 million euro grant for research into difficult-to-treat stomach cancer and the brain’s control of movement.

Immunotherapy

Discovery of new target in aggressive breast cancer opens door for new immunotherapy

Researchers from Erasmus MC have found a novel target for immunotherapy for an aggressive form of breast cancer. They isolated a receptor from white blood cells that recognizes the target and took the first steps towards a clinical treatment. “It was like searching for a needle in a haystack.”

Cell biology

Researchers break dogma: intestinal tumor does not always arise from stem cell

Scientists at Erasmus MC have discovered that intestinal tumors do not always originate from stem cells, contrary to the prevailing dogma. In the context of inflammation, specialized intestinal cells appear to be the origin of cancer.

Very High Energy Elektrons

Over 1 million euros for new form of radiation therapy

Exploring and optimizing a potential new form of radiation therapy using very high energy electrons. That is the focus of a new project by a team from the Erasmus MC Cancer Institute, TU Delft, and Lausanne University Hospital. The team has been awarded over 1 million euros from the Open Technology Programme of the Dutch […]

KWF grants subsidy of 0.9 million euros

New generation of immune cells against breast cancer

Prof. Dr. Reno Debets, researcher within the Internal Oncology department of the Erasmus MC Cancer Institute, has received a subsidy of over 900,000 euros from KWF for his research on new immune cells for the treatment of breast cancer. The aim of the research is to create, through a public-private partnership, a new generation of […]

Oncode Institute

Nitika Taneja new junior group leader in Oncode

University Associate Professor and group leader in the Department of Molecular Genetics Dr. Nitika Taneja has joined the group of scientists who will launch at Oncode Institute on Jan. 1.

Christiaan de Jong en Tahlita Zuiverloon

Bladder cancer

PCR test on bladder tumor predicts response to treatment

With a relatively simple test, urologists may be able to accurately determine in the future which patients will benefit from BCG bladder instillations. This is important because in 40 percent of patients, treatment is not successful, while treatment duration is lengthy and can cause unpleasant side effects.

ACE lecture

Collaboration essential for patients with hereditary and familial tumors

Joining the forces and expertise of clinicians, laboratory specialists and scientists is essential in providing the best care for people with hereditary and familial tumors. Erasmus MC’s ‘Academic Center for Familial and Hereditary tumors’ brings these groups together.